You can now read 5 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

Drug firm’s closure extended to Feb. 22

A Westborough drug company with the same owners as the Framingham specialty pharmacy at the center of the national fungal meningitis outbreak will remain closed until at least Feb. 22, public health regulators said Thursday.

Ameridose LLC, which voluntarily ceased operations Oct. 10, will remain shuttered while a joint investigation by state and federal authorities continues into “unsanitary conditions and questionable sterility practices at the facility,” according to a statement by the Massachusetts Department of Public Health.

Continue reading below

Since October, the department has secured a series of voluntary, temporary closure agreements with Ameridose to give state and federal investigators “maximum flexibility to complete their work,” according to the statement.

A November report by federal inspectors detailed 15 problems found at Ameridose, a major hospital drug supplier, ranging from insufficient testing of the sterility and potency of the drugs it made to the presence of vermin in an area where sterile products were packaged and stored.

Ameridose agreed to recall all of its more than 2,000 products Oct. 31, after the Food and Drug Administration said it had not found “adequate assurance of sterility” during an inspection.

An Ameridose spokesman said in a statement Thursday that the company submitted an initial response to the FDA on Dec. 4 regarding the sterility and other problems inspectors found at the facility, and submitted a supplemental response on Dec. 31.

More than 650 people have been sickened, and at least 39 have died, in the fungal meningitis outbreak tied to contaminated steroids made at the New England Compounding Center.

Hospital leaders have said the closure of Ameridose has exacerbated already existing shortages of a number of medications. To address that issue, state health regulators adopted emergency regulations late last year that allow hospitals to share compounded drugs they make in their own pharmacies with other hospitals.

Kay Lazar can be reached at Follow her on Twitter @GlobeKayLazar.
Loading comments...
Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
Please enter a valid email will never post anything without asking.
Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of